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of tick-borne encephalitis in a dog 
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Elina Andersson1* , Anna Kendall1, Angelika Url2, Angelika Auer3 and Michael Leschnik4
Abstract 
Background: Tick-borne encephalitis (TBE) is a zoonotic neurological disease caused by tick-borne encephalitis virus 
(TBEV), a flavivirus endemic in parts of Europe and Asia. Seroconversion without signs of clinical disease is common 
in dogs and most of the cases previously described have been tentatively diagnosed by combining neurologic signs 
with serum antibody titres. Here, the first Scandinavian RT-qPCR-confirmed clinical case of TBE in a dog is reported.
Case presentation: A 4-year old castrated male Pointer Labrador cross was presented with acute-onset ataxia. 
During hospitalisation, the dog developed seizures. Despite aggressive treatment with steroids, antimicrobials and 
sedation/anaesthesia, there was continued deterioration during the following 24 h after admission and the dog was 
euthanised and submitted for necropsy. Histopathological changes in the brain were consistent with lymphoplasma-
cytic and histiocytic meningoencephalomyelitis. RT-qPCR examination of the brain was positive for TBEV, confirming 
infection.
Conclusions: Meningoencephalomyelitis caused by TBEV should be a diagnostic consideration in dogs presenting 
with clinical signs of central nervous system disease such as acute-onset ataxia and seizures in areas where TBEV-posi-
tive ticks are endemic. Clinical TBE may be underdiagnosed in dogs due to lack of specific testing.
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Background
Tick-borne encephalitis (TBE) is a zoonotic neurological 
disease, caused by tick-borne encephalitis virus (TBEV) 
that belongs to the genus flavivirus and family Flaviviri-
dae [1]. The virus is endemic in parts of Asia and Europe. 
In Scandinavia, TBEV is endemic in Sweden, Finland 
and parts of Denmark and Norway [1, 2] and is of major 
health concern in humans. In Europe, approximately 
3000 human cases were reported annually between 2000 
and 2010 [2]. In Sweden, TBE case numbers in humans 
have increased during the last decade [3], from 174 cases 
in 2010 to a total of 358 cases in 2019, with a correspond-
ing incidence of 3.46 per 100,000 inhabitants [3]. The 
highest incidence is around the Mälaren Valley in the 
region of Uppsala, reaching 9.12 per 100,000 inhabitants 
in 2019 [3].
The European subtype of TBEV is transmitted mainly 
by the tick vector Ixodes ricinus, which is active between 
spring and autumn [1, 4–6]. This is the main tick vector 
responsible for disease transmission in Sweden [1, 7]. 
Ixodes persulcatus, the tick vector for the Far Eastern- 
and Siberian subtype of TBEV [1], was discovered for the 
first time in Sweden in 2015 [8]. Out of 276 Ixodes persul-
catus ticks collected in 2015–2016, all were negative for 
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TBEV [9]. The TBEV prevalence in the Swedish Ixodes 
ricinus tick population varies depending on study, tick 
stage and geographical location, ranging from 0.10 to 
4.48% [10].
In dogs, acute manifestation of TBE takes a mono-
phasic course with an estimated incubation period of 
5–9  days [11, 12]. Clinical signs include fever and neu-
rological abnormalities such as altered behaviour and 
consciousness, neck pain, hyperaesthesia, propriocep-
tive dysfunction, paresis, ataxia and seizures and well as 
cranial- and spinal nerve deficits [11–13]. Peracute and 
acute cases lead to death within a week [11]. Fatal out-
come is reported to occur in 16–50% of clinical cases of 
TBE in dogs [12, 14, 15]. The main pathological finding 
comprises lymphoplasmacytic and histiocytic inflamma-
tion in the cerebrum, meninges, brain stem and spinal 
cord [11, 13, 15–17]. In humans, the clinical symptoms 
and pathologic findings are similar to those in dogs, 
except for a biphasic course of disease [1, 18–21].
Only a few clinical cases of TBEV infection in dogs 
have been previously reported, occurring in Switzer-
land, Austria, Germany, Italy and Sweden [13, 22]. The 
first reported suspected Swedish canine TBE case was 
in 1960; a 5-year-old female Irish setter which developed 
neurological signs after exposure to ticks in the Stock-
holm archipelago [23]. Two more cases were described 
in 2001 and 2007 respectively [24, 25]. All of the previ-
ous Swedish cases have only been tentatively diagnosed 
by measuring serum antibody titres [23–25]. As fever 
and neurological signs occur early in the disease course 
in dogs, antibody response to TBEV infection may not be 
detectable in peracute and acute cases, where death may 
occur within a week [11, 12]. In addition, seroconver-
sion without clinical signs is common in dogs [11, 13, 15, 
26]. A rising antibody titre, although indicative of TBE in 
association with neurological signs, therefore does not 
provide a definitive diagnosis.
More reliable in  vivo diagnostic methods for TBE 
include polymerase chain reaction (PCR) examination 
of blood or cerebrospinal fluid (CSF) during the febrile, 
viraemic phase [11, 27, 28]. Post-mortem, PCR may 
be conducted on brain tissue and viral antigen may be 
detectable by immunohistochemical examination [11, 13, 
16]. The following report describes the first Scandinavian 
real-time polymerase chain reaction (RT-qPCR) con-
firmed case of clinical disease of TBE in a dog.
Case presentation
A 4-year old, 25  kg castrated male Pointer Labrador 
cross was admitted to the University Companion Animal 
Hospital at the Swedish University of Agricultural Sci-
ences in Uppsala in late August 2019 due to acute-onset 
ataxia. 24 h prior to admission the dog had been mildly 
obtunded and had shown mild discomfort on palpation 
of the thoracic spine. A positive response was seen after 
one dose of firocoxib (4.5 mg/kg per os) and the follow-
ing morning the dog was bright and alert but showed a 
single episode of mild proprioceptive deficits of the right 
hindlimb. There was deterioration during the day, and, 
in the afternoon, ataxia of all four limbs but mentation 
and appetite remained normal. The dog was from a rural 
area in the Mälaren Valley with access to forest walks and 
occasional attached ticks had been noted and removed 
throughout the summer. The dog had been treated with 
a single dose of fluralaner spot on  (Bravecto®, Intervet, 
Sweden) approximately 3 months prior to presentation.
On presentation the patient was very stressed and 
showed obvious ataxia with mild bilateral forelimb 
hypermetria. Cranial nerve functions were within normal 
limits. Palpation of the thoracic spine elicited a mild pain 
response, but there was no obvious pain on manipulation 
and palpation of the cervical spine. Rectal temperature 
was 39.1 °C. Cardiac auscultation could not be adequately 
performed due to heavy panting but mucous membranes 
were pink and moist. Abdominal palpation was nor-
mal. Serum biochemistry showed normal levels of liver 
enzyme activities and creatinine. A total blood count 
(CBC) was within normal limits but C-reactive protein 
(CRP) was mildly elevated at 14.3 mg/L (0–10 mg/L).
The dog was hospitalised and remained stable over 
night with good appetite and normal urination. The 
following morning during routine blood sampling 
(approximately 15 h after admission), the patient rapidly 
deteriorated. The ataxia worsened to the point where the 
dog could no longer remain ambulatory. The breathing 
turned into heavy panting and there was facial grimac-
ing with tense, retracted lips indicating involvement of 
the facial nerve and brain stem. Opisthotonus was noted 
but normal palpebral reflexes and pupillary light reflexes 
were still present bilaterally. Pain response and with-
drawal reflex was present in all four limbs.
Sedation was achieved with medetomidine (4  µg/kg), 
and subsequent medetomidine constant rate infusion 
(CRI) at 1 µg/kg/h. Due to the case being admitted dur-
ing a weekend with limited access to laboratory and other 
diagnostic modalities, no additional examinations were 
performed. As there was a clinical suspicion of menin-
goencephalitis, intravenous application of prednisolone 
acetate (2  mg/kg) and doctacillin (21  mg/kg) was initi-
ated. Despite an initial response to sedation, approxi-
mately 2  h after initiation of the medetomidine CRI, 
seizure-like activity with mild paddling of the forelimbs 
was noted. Midazolam was added to the CRI protocol at 
0.17  mg/kg/h and the medetomidine CRI increased to 
2 µg/kg/h. Despite this, seizures could not be controlled 
and the dog was therefore switched to a propofol CRI at 
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6 mg/kg/h. The dose had to be gradually increased during 
the following hours. Despite addition of midazolam CRI 
and increasing propofol CRI up to 30  mg/kg/h the sei-
zures could not be controlled. Overnight, the dog deteri-
orated with poor oxygenation and occasional episodes of 
apnea. When attempts were made to decrease the propo-
fol CRI, the seizures recurred. Due to continued deterio-
ration the dog was euthanised (approximately 30 h after 
admission) and submitted for necropsy.
Gross findings included two bilateral asymmetrical 
areas of haemorrhage in the superficial cortex of the 
frontal lobe of the brain, one in each hemisphere, meas-
uring 0.5  cm in diameter. The brain was diffusely con-
gested and slightly oedematous. No other gross findings 
were observed. The brain and spinal cord were fixed in 
10% neutral buffered formalin, routinely processed and 
stained with haematoxylin–eosin (HE). Sections of fron-
tal, parietal and temporal telencephalon, thalamus, hip-
pocampus, basal nuclei, mesencephalon, cerebellum and 
brain stem as well as the cervical, thoracal and lumbal 
portion of the spinal cord were histologically evaluated.
On microscopic examination, all sections of the brain 
and spinal cord showed multifocal to coalescing moder-
ate to severe inflammatory infiltrates composed of lym-
phocytes, plasma cells and histiocytes, located within 
the neuroparenchyma and surrounding vessels as up to 
10-layer thick perivascular cuffs (Fig.  1). In the brain, 
inflammation was seen in both white and grey matter, 
meanwhile in the spinal cord, inflammation was more 
pronounced in the grey matter of both dorsal and ventral 
horns. Most severe inflammatory changes were seen in 
the areas of thalamus, mesencephalon, brain stem and all 
segments of spinal cord. Multifocally, neuroparenchyma 
of both brain and spinal cord showed prominent nodu-
lar to diffuse gliosis with single cell necrosis (Fig.  2) as 
well as neuronal degeneration and microglia surrounding 
neuronal debris (interpreted as neuronophagia) (Fig.  3). 
The neuroparenchyma displayed mild to moderate rar-
efaction. Within the leptomeningeal subarachnoid space 
and surrounding leptomeningeal vessels in both brain 
and spinal cord were multifocal to coalescing infiltrates 
of mild to moderate numbers of lymphocytes, plasma 
cells and occasional histiocytes. No inclusion bodies were 
found. Three brain sections representing mesencephalon, 
cerebellum and brain stem were stained with Giemsa, 
with no additional findings. The histopathological 
Fig. 1 Photomicrograph showing a perivascular cuff consisting of 
lymphocytes, plasma cells and histiocytes in the brain stem. HE-stain. 
Bar: 50 µm
Fig. 2 Photomicrograph showing an area of diffuse gliosis with 
single cell necrosis (arrow) in the neuroparenchyma at the level of the 
mesencephalon. HE-stain. Bar: 50 µm
Fig. 3 Photomicrograph showing a necrotic neuron (arrow) 
surrounded by glial cells (interpreted as neuronophagia) in the 
thalamus. HE-stain. Bar: 50 µm
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changes were consistent with a lymphoplasmacytic and 
histiocytic meningoencephalomyelitis.
Immunohistochemical investigation of brain tis-
sue using a polyclonal rabbit antibody to TBEV (strain 
“Hochosterwitz, kindly provided by Prof. K. Stiasny, 
Dept. Virology, MedUni Vienna, Austria; dilution 1:500), 
was performed automatically on an autostainer (Lab 
Vision AS 360, Thermo Fisher Scientific, Waltham, MA, 
USA). Antigen retrieval was performed on deparaffinized 
and rehydrated sections by pronase digestion. Endog-
enous peroxidase activity was blocked by incubation 
in  H2O2, while background reduction was achieved by 
application of UV Protein Block (Thermo Scientific, Free-
mont, CA, USA). For detection of the primary antibody 
a secondary poly-HRP-goat anti-rabbit-IgG (BrightVision 
Poly-HRP-Anti Rb, Immunologic, VB Duiven, NL) was 
used followed by visualisation with DAB (DAB Quanto 
Substrate System, Thermo Scientific, Freemont, CA, 
USA). Subsequently, all sections were counterstained 
with haematoxylin, dehydrated and mounted. No specific 
staining for TBE could be noted in the sections. Brain 
sections from a mouse with experimental TBE served as 
positive control. For negative control, the primary anti-
body was omitted.
Paraffin-embedded brain tissue was submitted for RT-
qPCR examination. The tissue was deparaffinised using 
xylene and ethanol washes, thereafter tissue was digested 
by using tissue lysis buffer and Proteinase K (Qiagen, 
Hilden, Germany). For nucleic acid extraction, 140 µL 
of tissue lysate was used employing QIAamp Viral RNA 
Mini QIAcube Kit using QIAcube (Qiagen) accord-
ing to the manufacturer’s instructions. TBEV-specific 
sequences were detected by an RT-qPCR developed 
by Schwaiger et Cassinotti [27], with primers F-TBE 1: 
5′-GGG CGG TTC TTG TTC TCC-3′, R-TBE 1: 5′-ACA 
CAT CAC CTC CTT GTC AGA CT-3′ and TBE-specific 
probe TBE-Probe-WT: FAM-5′-TGA GCC ACC ATC 
ACC CAG ACA CA-3′-BHQ1 [27]. RT-qPCR was car-
ried out in a reaction volume of 20 µL using the qScript 
One-Step RT-qPCR Kit (Quantabio, Beverly, MA, USA) 
following the manufacturer’s guidelines. To ensure valid-
ity of the assays, positive and negative controls were 
included. The PCR was positive at a cycle threshold (CT) 
value of 30, confirming TBEV infection.
Discussion and conclusions
The examination of the brain and spinal cord in this case 
revealed a lymphoplasmacytic and histiocytic menin-
goencephalomyelitis caused by infection with TBEV, 
as confirmed by RT-qPCR. An alternative method for 
confirmation of clinical TBEV infection in  vivo in dogs 
includes PCR examination of serum or CSF [11, 28]. 
However, TBE viral nucleic acid is only detectable in 
serum during the initial viraemic phase, which may cor-
respond to a period when clinical signs are not yet fully 
exhibited [11, 28]. In addition, viraemia does not nec-
essarily lead to clinical disease and altogether this may 
make in vivo diagnosis by PCR from blood samples dif-
ficult in dogs.
In this case, diagnostic testing of brain tissue was per-
formed post mortem and the positive RT-qPCR result 
confirms TBEV infection. The immunohistochemi-
cal examination was negative for TBEV which is prob-
ably due to several factors. The method detects antigen 
without multiplication of the target, and is therefore less 
sensitive than PCR that targets DNA or RNA with subse-
quent multifold amplification of the nucleic acid. In the 
light of a PCR CT value of 30 the amount of viral antigen 
may also have been too low for detection by immuno-
histochemistry. Furthermore, rapid immunological viral 
clearance in the brain and CSF may have caused a false 
negative immunohistochemical result [16, 29].
In this case, no in vivo testing for TBEV was attempted 
due to lack of awareness of TBE as a potential differential 
diagnosis. In the light of the increased TBEV infection 
incidence in humans and the expansion of endemic areas 
during the last decades [2, 3], TBE should be considered 
as a possible differential diagnosis in dogs exhibiting neu-
rological signs.
The main pathological finding in this case, comprising 
lymphoplasmacytic and histiocytic inflammation within 
the brain and spinal cord, reflects the clinical signs of 
meningoencephalomyelitis. The histopathological pat-
tern of neural non-purulent inflammation is in itself 
unspecific but suggestive of viral infection [17]. Many 
of the possible histopathological differential diagnoses 
either comprise viral encephalitidies that do not cur-
rently occur in Sweden, such as West Nile virus infec-
tion and rabies, or have attributes that do not fit in with 
the clinical presentation of this case. In addition to this, 
the histopathological findings were consistent with the 
changes seen in a retrospective post-mortem examina-
tion of brain tissue from eight Austrian dogs with clini-
cal TBE confirmed by immunohistochemistry, except for 
the absence of glial shrubbery in the cerebellum [16]. In 
both the Austrian study and this study, changes included 
lymphohistiocytic meningitis, neuronal necrosis and 
neuronophagia, gliosis and non-purulent perivascular 
cuffing in the neuroparenchyma. In this case, the most 
severe changes were seen in the thalamus, mesencepha-
lon, brainstem and spinal cord, which is in high accord-
ance with the Austrian results.
In conclusion, this case report shows that meningoen-
cephalomyelitis caused by TBEV should be a diagnostic 
consideration in dogs presenting with clinical signs of neu-
rological disease such as acute-onset ataxia and seizures in 
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areas where TBEV-positive ticks are endemic [2, 3]. In vivo 
PCR testing of blood or, preferably, CSF should be included 
as part of the work up of suspected cases. Furthermore, 
awareness should be raised that in times of climate change 
and warmer weather, ticks may be active for longer periods 
of the year [30–32] and clinical cases of TBE in dogs may 
be encountered during a larger part of the year in endemic 
areas in the future.
Abbreviations
CBC: Complete blood count; CRI: Constant rate infusion; CRP: C-reactive pro-
tein; CSF: Cerebrospinal fluid; CT: Cycle threshold; DAB: 3′3-Diaminobenzidine; 
HE: Haematoxylin and eosin; HRP: Horseradish peroxidase; IHC: Immunohis-
tochemistry; PCR: Polymerase chain reaction; RT-qPCR: Real-time polymerase 
chain reaction; TBE: Tick-borne encephalitis; TBEV: Tick-borne encephalitis virus.
Acknowledgements
The authors wish to thank Vidar Andersson, Albin Norman and Peder Eriksson 
for excellent technical support.
Prior publication
A small part of this manuscript data has been contributed to the 2020–2021 
Wednesday Slide Conference (WSC) arranged by the US organisation Joint 
Pathology Center (JPC) Veterinary Pathology Services. The manuscript submit-
ted to Acta Veterinaria Scandinavica differs significantly from that included in 
the WSC contribution.
Authors’ contributions
EA conducted the necropsy and evaluated the histopathology. AU and AA 
performed the specific diagnostic testing. EA, AK and ML drafted the manu-
script. All authors read and approved the final manuscript.
Funding
Open access funding provided by Swedish University of Agricultural Sciences.
Availability of data and materials
The datasets used and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Ethics approval and consent to participate
This study did not require official or institutional ethical approval. The animals 
were handled in accordance with high ethical standards and national 
legislation.
Consent for publication
Informed owner content was obtained for the publication of this report.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Section of Pathology, Department of Biomedical Sciences and Veterinary 
Public Health, Faculty of Veterinary Medicine and Animal Science, Swed-
ish University of Agricultural Sciences (SLU), Uppsala, Sweden. 2 Institute 
of Pathology, Department of Pathobiology, University of Veterinary Medicine, 
Vienna, Austria. 3 Institute of Virology, Department of Pathobiology, University 
of Veterinary Medicine, Vienna, Austria. 4 Small Animal Clinic, Department 
for Companion Animals, University of Veterinary Medicine, Vienna, Austria. 
Received: 7 April 2020   Accepted: 2 September 2020
References
 1. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. 
2008;371:1861–71.
 2. European Centre for Disease Prevention and Control: Epidemiological 
situation of tick-borne encephalitis in the European Union and European 
Free Trade Association countries. 2012 https ://www.ecdc.europ a.eu/sites 
/defau lt/files /media /en/publi catio ns/Publi catio ns/TBE-in-EU-EFTA.pdf. 
Accessed 17 Mar 2020.
 3. Folkhälsomyndigheten: Tick-borne encephalitis. https ://www.folkh alsom 
yndig heten .se/folkh alsor appor terin g-stati stik/stati stik-a-o/sjukd omsst 
atist ik/tick-borne -encep halit is-tbe/?t=count y. Accessed 22 Jul 2020.
 4. Nilsson A. Seasonal occurence of Ixodes ricius (Acari) in vegetation and on 
small mammals in Southern Sweden. Oikos. 1988;11:161–5.
 5. Mejlon HA, Jaenson TG. Seasonal prevalence of Borrelia burgdorferi in 
Ixodes ricinus in different vegetation types in Sweden. Scand J Infect Dis. 
1993;25:449–56.
 6. Perret JL, Guigoz E, Rais O, Gern L. Influence of saturation deficit and 
temperature on Ixodes ricinus tick questing activity in a lyme borreliosis-
endemic area (Switzerland). Parasitol Res. 2000;86:554–7.
 7. Jaenson TG, Tälleklint L, Lundqvist L, Olsen B, Chirico J, Mejlon H. Geo-
graphical distribution, host associations, and vector roles of ticks (Acari: 
Ixodidae, Argasidae) in Sweden. J Med Entomol. 1994;31:240–56.
 8. Jaenson TG, Värv K, Fröjdman I, Jääskeläinen A, Rundgren K, Versteirt V, 
et al. First evidence of established populations of the taiga tick Ixodes 
persulcatus (Acari: Ixodidae) in Sweden. Parasites Vectors. 2016;9:377.
 9. Jaenson TG, Wilhelmsson P. First records of tick-borne pathogens in 
populations of the taiga tick Ixodes persulcatus in Sweden. Parasites Vec-
tors. 2019;12:559.
 10. Pettersson JH, Golovljova I, Vene S, Jaenson TG. Prevalence of tick-borne 
encephalitis virus in Ixodes ricinus ticks in northern Europe with particular 
reference to Southern Sweden. Parasites Vectors. 2014;7:102.
 11. Leschnik MW, Kirtz GC, Thalhammer JG. Tick-borne encephalitis (TBE) in 
dogs. Int J Med Microbiol. 2002;291:66–9.
 12. Leschnik MW, Benetka V, Url A, Pakozdy A, Thaller D, Bilek A, et al. Virale 
enzephalitiden beim hund in Österreich: diagnostische und epidemiolo-
gische aspekte. Wien Tierarztl Monatsschr. 2008;7–8:190–9.
 13. Pfeffer M, Dobler G. Tick-borne encephalitis virus in dogs—is this an 
issue? Parasites Vectors. 2011;4:59.
 14. Tipold A, Fatzer R, Holzmann H. Zentraleuropäische Zeckenenzephalitis 
beim Hund. Kleintierpraxis. 1993;38:619–28.
 15. Kirtz G. FSME-Infektion in einer Österreichischen Hunde-population. 
Wien: Diss Vet Med Univ; 1999.
 16. Weissenböck H, Suchy A, Holzmann H. Tick-borne encephalitis in dogs: 
neuropathological findings and distribution of antigen. Acta Neuro-
pathol. 1998;95:361–6.
 17. Cantile C, Youssef S. Nervous System. In: Maxie MG, editor. Jubb, Kennedy 
and Palmer’s Pathology of Domestic Animals. Philadelphia: PA Saunders 
Elsevier; 2015. p. 250–406.
 18. Kaiser R. The clinical and epidemiological profile of tick-borne encepha-
litis in southern Germany 1994-98: a prospective study of 656 patients. 
Brain. 1999;122:2067–78.
 19. Kaiser R. Tick-borne encephalitis (TBE) in Germany and clinical course of 
the disease. Int J Med Microbiol. 2002;291:58–61.
 20. Günther G, Haglund M, Lindquist L, Forsgren M, Sköldenberg B. Tick-bone 
encephalitis in Sweden in relation to aseptic meningo-encephalitis of 
other etiology: a prospective study of clinical course and outcome. J 
Neurol. 1997;244:230–8.
 21. Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka H. Visualiza-
tion of Central European tick-borne encephalitis infection in fatal human 
cases. J Neuropathol Exp Neurol. 2005;64:506–12.
 22. Weissenböck H, Holzmann H. Immunohistological diagnosis of tick-borne 
encephalitis in Austrian dogs. Wien Tierarztl Monatsschr. 1997;2:34–8.
 23. Lindblad G. Ett fall av fästingburen encephalit hos hund. Medlemsblad 
för Sveriges veterinärförbund. 1960;12:416–7.
 24. Ytterberg U, Bjöersdorff A. TBE hos hund – en fallbeskrivning. Svensk Vet 
Tidn. 2002;54:5–7.
 25. Åblad B. TBE hos en tvåårig hund i Västra Götaland. Svensk Vet Tidn. 
2007;59:21–3.
 26. Leschnik M, Feiler A, Duscher GG, Joachim A. Effect of owner-controlled 
acaricidal treatment on tick infestation and immune response to 
tick-borne pathogens in naturally infested dogs from Eastern Austria. 
Parasites Vectors. 2013;6:62.
Page 6 of 6Andersson et al. Acta Vet Scand           (2020) 62:51 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 27. Schwaiger M, Cassinotti P. Development of a quantitative real-time RT-
PCR assay with internal control for the laboratory detection of tick borne 
encephalitis virus (TBEV) RNA. J Clin Virol. 2003;27:136–45.
 28. Hekrlová A, Kubíček O, Lány P, Rosenbergová K, Schánilec P. Tick-borne 
encephalitis in dogs: application of “nested real-time RT-PCR” for intravital 
virus detection. Berl Munch Tierarztl Wochenschr. 2015;128:397–401.
 29. Pfeffer M, Leschnik M. TBE in animals: disease, infection source, reservoir 
host, and sentinel for human infection risk. In: Dobler G, Erber W, Schmitt 
HJ, editors. Tick-borne encephalitis (TBE) – The book. Singapore: Global 
Health Press; 2018. p. 91–102.
 30. Lindgren E, Gustafson R. Tick-borne encephalitis in Sweden and climate 
change. Lancet. 2001;358:16–8.
 31. Gray JS. Ixodes ricinus seasonal activity: implications of global warm-
ing indicated by revisiting tick and weather data. Int J Med Microbiol. 
2008;298:19–24.
 32. Daniel M, Danielová V, Fialová A, Malý M, Kříž B, Nuttall PA. Increased 
relative risk of tick-borne encephalitis in warmer weather. Front Cell Infect 
Microbiol. 2018;8:90.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
